Medicine & Life Sciences
Platinum
100%
Cisplatin
82%
ormaplatin
24%
Carboplatin
22%
Neoplasms
22%
1,2-cyclohexanediamine
19%
1R,2R-diaminocyclohexane
16%
Pharmaceutical Preparations
15%
Amines
14%
Ligands
13%
((1R,2R)-1,2-diaminocyclohexane)platinum(II)
13%
DNA Adducts
12%
Antineoplastic Agents
12%
Cell Line
12%
Pharmacokinetics
12%
Leukemia L1210
12%
Kidney
11%
Ovarian Neoplasms
11%
Oxaliplatin
11%
Fever
10%
DNA Damage
10%
Carcinoma
9%
bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)
9%
Liver
9%
(diaminocyclohexane)(diacetato)(dichloro)platinum
9%
Liposomes
9%
Lysergic Acid
8%
In Vitro Techniques
7%
Copper Transport Proteins
7%
texaphyrin
7%
Lung
7%
(ammine)cyclohexylaminedichloroplatinum(II)
7%
1,1-cyclobutane dicarboxylate
7%
Glutathione
7%
Paraquat
7%
Hot Temperature
7%
Pharmacology
6%
Paraquat lung
6%
Lysergic Acid Diethylamide
6%
Inhibitory Concentration 50
5%
Drug Resistance
5%
Acetates
5%
Imipramine
5%
Tumor Cell Line
5%
1,4-diaminocyclohexane
5%
Bleomycin
5%
DNA
5%
Vitamin A Deficiency
5%
Small Interfering RNA
5%
Chemistry
Platinum
40%
Cisplatin
39%
Antitumor
25%
195Pt NMR Spectroscopy
12%
Drug
10%
Carboplatin
9%
Resistance
9%
Elemental Analysis
8%
Lysergic Acid
7%
Pharmacological Metabolism
7%
Texaphyrin
7%
Glutathione
6%
Dose
6%
Paraquat
6%
Amine
5%
Adduct
5%
Antineoplastic Agent
5%